Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × NKTR-255 × 90 days × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

fludarabine 4 Cyclophosphamide 4 blinatumomab 3 Melphalan 3 pembrolizumab 2 fludarabine phosphate 2 Lenalidomide 2 Dexamethasone 2 Cytarabine 2 Capecitabine 2 venetoclax 1 trastuzumab deruxtecan 1 tislelizumab 1 tisagenlecleucel 1 thymoglobulin 1 tetrathiomolybdate 1 tagraxofusp 1 relugolix 1 palbociclib 1 nilotinib 1 ixazomib 1 isatuximab 1 inavolisib 1 giredestrant 1 enzalutamide 1 avelumab 1 abemaciclib 1 Whole-Body Irradiation 1 Trastuzumab 1 Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡